Organon appoints Ramona A. Sequeira to Board of Directors

Organon & Co.

Appointment effective July 1, 2025; Board expands to 12 directors.
Sequeira will serve on the Talent Committee of the Board.
She is President of Global Portfolio Division at Takeda with 30+ years pharma experience.
No related-party transactions or family relationships disclosed.
Standard non-employee director compensation applies; indemnification agreement to be entered.

item 5.02 item 7.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Ramona A. Sequeira

Director

OGN · Organon & Co.

Effective: 2025-07-01
Filed: April 15, 2025, 7:59 PM ET

the appointment of Ramona A. Sequeira will become immediately effective to fill the resulting vacancy.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Ramona A. Sequeira was appointed as Director at Organon & Co..

Action: appointed
Role: Director

Exact text from the filing

the appointment of Ramona A. Sequeira will become immediately effective to fill the resulting vacancy.

View on SEC.gov

Organon & Co. filing history →

Source: SEC EDGAR

accession 0001104659-25-035173

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.